Insulin-like growth factors and breast cancer
- 1 January 1995
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 49 (9) , 415-421
- https://doi.org/10.1016/0753-3322(96)82678-3
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 geneNature, 1994
- A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor.Molecular and Cellular Biology, 1994
- Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)European Journal Of Cancer, 1993
- Role of insulin-like growth factors in embryonic and postnatal growthCell, 1993
- Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-IMolecular Endocrinology, 1993
- IGF-I and IGF-II expression in human breast cancer xenografts: Relationship to hormone independenceBreast Cancer Research and Treatment, 1992
- Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.Journal of Clinical Investigation, 1989
- Binding proteins for the insulin-like growth factors: Structure, regulation and functionProgress in Growth Factor Research, 1989
- Hormonal Control of Immunoreactive Somatomedin Production by Cultured Human FibroblastsJournal of Clinical Investigation, 1981
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896